LNCaP In Vitro Reactive Oxygen Species Assay (Oxidative Stress)
CAT#: ITS-1022-YF903
Target Cell Organism: Human
Target Cell Name: LNCaP
Assay Type: Oxidative Stress Assays
Assay Overview
This assay is to provide LNCaP-based In Vitro Reactive Oxygen Species Assay (Oxidative Stress) to accelerate our client's oncology projects. The assay will be customized according to the specific requirements. Please contact our scientists to discuss more details.
Target Cell Name
LNCaP
Target Cell Organism
Human
Target Cell Background
The LNCaP cell line was originally isolated from the lymph node of a patient with metastatic prostate cancer. Many cell lines have been derived from LNCaP by selective pressures to study different aspects of prostate cancer progression.
Related Diseases
Prostate Adenocarcinoma
Research Area
Oncology
Assay Name
In Vitro Reactive Oxygen Species Assay (Oxidative Stress)
Short Description
LNCaP-cell based In Vitro Reactive Oxygen Species Assay (Oxidative Stress)
Assay Type
Oxidative Stress Assays
Assay Type Details
Disturbance between the production of reactive oxygen species (ROS), free radicals and antioxidant mechanisms is defined as the oxidative stress, or more precisely, it is an imbalance between the oxidant and antioxidant state in cells. This imbalance can cause harmful effects to cells and biomolecules, which ultimately causes adverse effects in the whole organism. Oxidative imbalance can target important proteinsand lipids in cells, which can increase the risk of developing a cancer. On the other hand, increased ROS production in cancer cells by certain cancer drugs can also arrest cancer cell cycle and cause senescence and apoptosis through oxidative stress.